Search alternatives:
resolvessdsssds. » resolvedsdsssds. (Expand Search), evolvessdsssds. (Expand Search), resolvedssdsssds. (Expand Search)
resolves. » resolved. (Expand Search), evolves. (Expand Search), resolveds. (Expand Search)
resolve. » resolved. (Expand Search)
resolvessdsssds. » resolvedsdsssds. (Expand Search), evolvessdsssds. (Expand Search), resolvedssdsssds. (Expand Search)
resolves. » resolved. (Expand Search), evolves. (Expand Search), resolveds. (Expand Search)
resolve. » resolved. (Expand Search)
-
481
-
482
-
483
-
484
Comparison of <i>Eh</i>A1 and <i>Eh</i>B2 EV proteomes to the Top 100 mammalian EV proteins.
Published 2025Subjects: -
485
-
486
Molecular function GO term enrichment of proteins present in <i>Eh</i>A1 but not <i>Eh</i>B2 EVs.
Published 2025Subjects: -
487
Differential expression analysis of novel miRNAs identified in <i>Eh</i>A1 and <i>Eh</i>B2 EVs.
Published 2025Subjects: -
488
Analysis of GO terms enriched or depleted in EV proteomes compared with trophozoite proteomes.
Published 2025Subjects: -
489
-
490
-
491
Distribution of SCCmec types according to antibiotic resistance phenotypes for MRSA.
Published 2022Subjects: -
492
-
493
-
494
Cellular uptake of <i>E. histolytica</i> EVs and activation of primary monocytes.
Published 2025Subjects: -
495
-
496
-
497
-
498
-
499
-
500
Secondary antibody controls for immunogold labeling of <i>Eh</i>A1 and <i>Eh</i>B2 EVs.
Published 2025Subjects: